##gff-version 3
##sequence-region P08913 1 450
P08913	UniProtKB	Chain	1	450	.	.	.	ID=PRO_0000069080;Note=Alpha-2A adrenergic receptor	
P08913	UniProtKB	Topological domain	1	33	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Transmembrane	34	59	.	.	.	Note=Helical%3B Name%3D1;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Topological domain	60	70	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Transmembrane	71	96	.	.	.	Note=Helical%3B Name%3D2;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Topological domain	97	106	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Transmembrane	107	129	.	.	.	Note=Helical%3B Name%3D3;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Topological domain	130	151	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Transmembrane	152	172	.	.	.	Note=Helical%3B Name%3D4;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Topological domain	173	194	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Transmembrane	195	217	.	.	.	Note=Helical%3B Name%3D5;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Topological domain	218	374	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Transmembrane	375	395	.	.	.	Note=Helical%3B Name%3D6;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Topological domain	396	409	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Transmembrane	410	429	.	.	.	Note=Helical%3B Name%3D7;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Topological domain	430	450	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Site	113	113	.	.	.	Note=Implicated in ligand binding	
P08913	UniProtKB	Site	200	200	.	.	.	Note=Implicated in catechol agonist binding and receptor activation	
P08913	UniProtKB	Site	204	204	.	.	.	Note=Implicated in catechol agonist binding and receptor activation	
P08913	UniProtKB	Modified residue	331	331	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P22909	
P08913	UniProtKB	Modified residue	353	353	.	.	.	Note=Omega-N-methylarginine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q01338	
P08913	UniProtKB	Lipidation	442	442	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P08913	UniProtKB	Glycosylation	10	10	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P08913	UniProtKB	Glycosylation	14	14	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P08913	UniProtKB	Disulfide bond	106	188	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00521	
P08913	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_014957;Note=Rare polymorphism%3B frequency in Caucasians 0.004 and in African-Americans 0.05%3B 40%25 increase in agonist-promoted Gi coupling. N->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10948191,ECO:0000269|PubMed:16567612,ECO:0000269|Ref.9;Dbxref=dbSNP:rs1800035,PMID:10948191,PMID:16567612	
P08913	UniProtKB	Natural variant	401	401	.	.	.	ID=VAR_055908;Note=C->S;Dbxref=dbSNP:rs35658213	
P08913	UniProtKB	Mutagenesis	79	79	.	.	.	Note=No change in binding affinity. eliminates guanine nucleotide-sensitive agonist binding. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1678850;Dbxref=PMID:1678850	
P08913	UniProtKB	Mutagenesis	113	113	.	.	.	Note=No binding to yohimbine. Increase in adenylate cyclase activity. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1678850;Dbxref=PMID:1678850	
P08913	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Lower affinity for agonists. Eliminates guanine nucleotide-sensitive agonist binding. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1678850;Dbxref=PMID:1678850	
P08913	UniProtKB	Mutagenesis	200	200	.	.	.	Note=Lower affinity for agonists. No change in guanine nucleotide-sensitive agonist binding. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1678850;Dbxref=PMID:1678850	
P08913	UniProtKB	Mutagenesis	204	204	.	.	.	Note=Lower affinity for agonists. Reduced guanine nucleotide-sensitive agonist binding. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1678850;Dbxref=PMID:1678850	
P08913	UniProtKB	Mutagenesis	412	412	.	.	.	Note=350-fold reduced affinity for alpha-2 antagonist yohimbine%2C 3000-fold increase for beta-antagonist alprenolol. F->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1678390;Dbxref=PMID:1678390	
P08913	UniProtKB	Sequence conflict	104	104	.	.	.	Note=A->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P08913	UniProtKB	Sequence conflict	124	124	.	.	.	Note=L->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P08913	UniProtKB	Sequence conflict	157	157	.	.	.	Note=V->C;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P08913	UniProtKB	Sequence conflict	333	365	.	.	.	Note=PRRGPGATGIGTPAAGPGEERVGAAKASRWRGR->RGAGRGRRGSGRRLQGRGRSASGLPRRRAGAGG;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P08913	UniProtKB	Sequence conflict	333	365	.	.	.	Note=PRRGPGATGIGTPAAGPGEERVGAAKASRWRGR->RGAGRGRRGSGRRLQGRGRSASGLPRRRAGAGG;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P08913	UniProtKB	Sequence conflict	368	368	.	.	.	Note=R->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P08913	UniProtKB	Helix	119	128	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1HLL	
P08913	UniProtKB	Helix	130	139	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1HLL	
P08913	UniProtKB	Helix	140	142	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1HLL	
